Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: FDA's Division of General and Restorative Devices

This article was originally published in The Gray Sheet

Executive Summary

FDA's Division of General and Restorative Devices: Office of Device Evaluation division assumes responsibility for all neurological device premarket reviews effective Oct. 1. Formerly reviewed by ODE's Division of Cardiovascular, Respiratory and Neurological Devices, responsibility for the products was transferred to DGRD to prevent any overlap of efforts resulting from the restorative nature of the neurological products, FDAers say. Two DCRND reviewers have moved to DGRD, which will spread the added workload among the four existing branches as appropriate...

You may also be interested in...



Respiratory Device Hand-off To FDA Dental Group Intended To Achieve Parity

Responsibility for reviewing respiratory device-related premarket submissions is expected to be transferred out of FDA's Division of Cardiovascular and Respiratory Devices (DCRD) to the Division of Dental, Infection Control and General Hospital Use Devices (DDIGD).

Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori

The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker

UsernamePublicRestriction

Register

OM017175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel